Skip to Content

Press Releases

Press Releases

Jun 19 2019
Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders
JERUSALEM , June 19, 2019 /PRNewswire/ -- Intec Pharma Ltd.  (NASDAQ: NTEC) (" Intec " or "the Company") today announced that results from a pharmacokinetics (PK) study of the Accordion Pill™-Carbidopa/Levodopa (AP-CD/LD) 50/500 mg dosed three times per day (TID) were highlighted yesterday in a
May 28 2019
Intec Pharma to Participate at June Investment Conferences
JERUSALEM , May 28, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that Company management will participate at the following upcoming investment conferences in June.  Jefferies Global Healthcare Conference Date: June 4-7, 2019 Company
May 20 2019
Intec Pharma Granted European Patent
Strengthens Protection for Accordion Pill Platform JERUSALEM , May 20, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF
May 16 2019
Intec Pharma Announces Research Collaboration Agreement With Merck
NEW YORK , May 16, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces it has entered into an agreement with Merck, known as MSD outside the United States and Canada , to explore using the Accordion Pill ® (AP) platform for an undisclosed development
May 07 2019
Intec Pharma Reports First Quarter 2019 Financial Results and Corporate Update
JERUSALEM , May 7, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces financial results for the three months ended March 31, 2019 and provides a corporate update.  Highlights of the first quarter 2019 and recent weeks include: Announced that the last
May 02 2019
Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders
JERUSALEM , May 2, 2019 /PRNewswire/  -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that the results from a pharmacokinetics (PK) study of the Accordion Pill™-Carbidopa/Levodopa (AP-CD/LD) 50/500 mg dosed three times per day (TID) was accepted for presentation in
Apr 30 2019
Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill™ Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Company on track to report top-line data in July/August time frame JERUSALEM , April 30, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that the last patient has completed their final visit in the Company's pivotal Phase 3 trial (the ACCORDANCE
Apr 01 2019
Intec Pharma to Participate in the HC Wainwright Global Life Sciences Conference
JERUSALEM , April 1, 2019 /PRNewswire/ --  Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that Company management will participate in the upcoming HC Wainwright Global Life Sciences Conference . HC Wainwright Global Life Sciences Conference Date: April 7-9, 2019
Mar 13 2019
Intec Pharma Announces Time Change for Presentation at Barclays Global Healthcare Conference
Presenting at 8:00 am Eastern time on March 14, 2019 JERUSALEM , March 13, 2019 /PRNewswire/ --   Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that the Company's presentation time at Barclays Global Healthcare Conference has been changed as follows.
Feb 28 2019
Intec Pharma to Participate at Four Investment Conferences in March
JERUSALEM , Feb. 28, 2019 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (" Intec " or "the Company") today announces that Company management will participate at the following upcoming investment conferences in March.  Cowen 39th Annual Health Care Conference Date: March 11-13, 2019 Company
Displaying 1 - 10 of 89